Renal functional and structural studies in young patients with chronic kidney disease
- Prosjektnummer
- 911960
- Ansvarlig person
- Camilla Tøndel
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Renal and Urogenital
- Forskningsaktivitet
- 6. Treatment Evaluation, 7. Disease Management
Samhandling med pasienter, foreldre og pasientforening.
Early start of enzyme replacement therapy in pediatric male patients with classical Fabry disease is associated with attenuated disease progression.
Mol Genet Metab 2021 Dec 17. Epub 2021 des 17
PMID: 35033446
Accuracy of single intravenous access iohexol GFR in children is hampered by marker contamination.
Sci Rep 2021 12 01;11(1):23224. Epub 2021 des 1
PMID: 34853376
Efficacy and safety of mirabegron in children and adolescents with neurogenic detrusor overactivity: An open-label, phase 3, dose-titration study.
Neurourol Urodyn 2021 08;40(6):1490-1499. Epub 2021 mai 31
PMID: 34058027
Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus.
Mol Genet Metab 2021 04;132(4):234-243. Epub 2021 feb 20
PMID: 33642210
Measurement of renal functional response using iohexol clearance-a study of different outpatient procedures.
Clin Kidney J 2021 Jan;14(1):181-188. Epub 2019 nov 26
PMID: 33564417
Growth Differentiation Factor 15 in Children with Chronic Kidney Disease and after Renal Transplantation.
Dis Markers 2020;2020():6162892. Epub 2020 feb 6
PMID: 32089755
Accumulation of Globotriaosylceramide in Podocytes in Fabry Nephropathy Is Associated with Progressive Podocyte Loss.
J Am Soc Nephrol 2020 04;31(4):865-875. Epub 2020 mar 3
PMID: 32127409
Low birthweight is associated with lower glomerular filtration rate in middle-aged mainly healthy women.
Nephrol Dial Transplant 2021 Dec 31;37(1):92-99.
PMID: 33313893
Estimating glomerular filtration rate in children: evaluation of creatinine- and cystatin C-based equations.
Pediatr Nephrol 2019 02;34(2):301-311. Epub 2018 aug 31
PMID: 30171354
Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial.
Mol Genet Metab 2019 05;127(1):86-94. Epub 2019 apr 3
PMID: 30987917
The pharmacokinetics, safety, and tolerability of mirabegron in children and adolescents with neurogenic detrusor overactivity or idiopathic overactive bladder and development of a population pharmacokinetic model-based pediatric dose estimation.
J Pediatr Urol 2019 Oct 22. Epub 2019 okt 22
PMID: 31787582
European expert consensus statement on therapeutic goals in Fabry disease.
Mol Genet Metab 2018 Jul;124(3):189-203. Epub 2018 jun 12
PMID: 30017653
The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease - A systematic literature review by a European panel of experts.
Mol Genet Metab 2018 Apr 26. Epub 2018 apr 26
PMID: 29785937
Iohexol plasma clearance in children: validation of multiple formulas and two-point sampling times.
Pediatr Nephrol 2017 Feb;32(2):311-320. Epub 2016 jul 1
PMID: 27369694
Long-Term Dose-Dependent Agalsidase Effects on Kidney Histology in Fabry Disease.
Clin J Am Soc Nephrol 2017 Sep 07;12(9):1470-1479. Epub 2017 jun 16
PMID: 28625968
Bedside Stereomicroscopy of Fabry Kidney Biopsies: An Easily Available Method for Diagnosis and Assessment of Sphingolipid Deposits.
Nephron 2017 Aug 26. Epub 2017 aug 26
PMID: 28848191
Iohexol plasma clearance in children: validation of multiple formulas and single-point sampling times.
Pediatr Nephrol 2018 Apr;33(4):683-696. Epub 2017 nov 13
PMID: 29134449
Reaccumulation of globotriaosylceramide in podocytes after agalsidase dose reduction in young Fabry patients.
Nephrol Dial Transplant 2017 May 01;32(5):807-813.
PMID: 27190352
Pathomechanisms of renal Fabry disease.
Cell Tissue Res 2017 Jul;369(1):53-62. Epub 2017 apr 12
PMID: 28401309
One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease.
PLoS One 2016;11(4):e0152812. Epub 2016 apr 15
PMID: 27081853
Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria.
Nephron 2015;129(1):16-21. Epub 2014 des 17
PMID: 25531941
Glomerular filtration rate measured by iohexol clearance: A comparison of venous samples and capillary blood spots.
Scand J Clin Lab Invest 2015;75(8):710-6.
PMID: 26426851
Cardiovascular changes in young renal failure patients
Clinical Kidney Journal, 2021 nov 11, https://doi.org/10.1093/ckj/sfab223
Measurement of renal functional response using iohexol clearance — a study of different outpatient procedures
Clin Kidney J, epub 26Nov2019
Renal Function Influences Diagnostic Markers in Serum and Urine: A Study of Guanidinoacetate, Creatine, Human Epididymis Protein 4, and Neutrophil Gelatinase–Associated Lipocalin in Children
J Appl Lab Med 2017 Nov 2.(3) 297-308
- Einar Svarstad Medveileder
- Hans-Peter Marti Hovedveileder
- Camilla Tøndel Postdoktor
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest